We also discovered that driver events in the private subclones of both samples, such as alterations in <i>CDC27</i> and <i>RUNX1</i>, might have played a significant role in tumor progression or even neuroendocrine differentiation. This evidence concerns the gene RUNX1 and neoplasm.